Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
HIV prevention
Marketing
'One2PrEP': Gilead's 1st Yeztugo ad highlights biannual dosing
As it ramps up the rollout of its twice-yearly HIV PrEP med, Gilead is tapping into a beloved early-aughts hit to familiarize consumers with Yeztugo.
Andrea Park
Mar 2, 2026 3:39pm
‘Pieces are coming together’ amid Gilead's Yeztugo launch: exec
Feb 11, 2026 11:34am
CDC 'strongly recommends' Gilead's HIV PrEP Yeztugo
Sep 19, 2025 11:22am
CVS won't cover Gilead's twice-yearly PrEP drug Yeztugo—for now
Aug 21, 2025 3:02pm
With FDA nod, Gilead adds twice-yearly option to PrEP landscape
Jun 18, 2025 2:32pm
Potential US budget cuts have limited impact on Gilead: analysts
Mar 26, 2025 2:47pm
